Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Kennel Club to host webinar on haemangiosarcoma
The webinar will include a one-hour presentation and a question and answer session.
Topics covered will include symptoms and treatment options.

The Kennel Club is set to host a free webinar on haemangiosarcom for veterinary professionals, breeders and owners.

The session, organised by The Kennel Club’s health team, will take place between 7-8.30pm on Wednesday, 7 August.

The speaker will be Mark Goodfellow, head of oncology at Davies Veterinary Specialists. He is a European Specialist in Veterinary Internal Medicine, an RCVS Specialist in Veterinary Oncology, and has a DPhil in molecular oncology from the University of Oxford.

Haemangiosarcom can present in serveral forms, including cutaneous, subcutaneous and visceral. Symptoms can be subtle and may not be noticed until the tumour spreads or ruptures.

During the webinar, Dr Goodfellow will talk about the research into haemangiosarcom, including breed susceptibilities, symptoms, diagnostic approaches, and possible treatment options. He will also explore what future research could reveal.

After a one-hour presentation, there will be a 30-minute question and answer session. Questions can be asked during the webinar or pre-submitted when registering.

For those interested in learning more about canine cancers, there is also a previous webinar about osteosarcoma available to watch on YouTube, alongside other health webinars from The Kennel Club. The speaker was Mark Dunning, a professor of small animal internal medicine at the University of Nottingham who has led various research projects into osteosarcoma.

Those interested in attending the webinar on haemangiosarcom can book a place here.

Image © Shutterstock

Become a member or log in to add this story to your CPD history

Zoetis apologises for EVA vaccine shortage

News Story 1
 Zoetis UK has apologised for a supply shortage of Equip Artervac, caused by a manufacturing issue.

It is expected to become available in June 2025.

Equip Artervac is used for the active immunisation for horses against equine viral arteritis (EVA) to reduce the clinical signs and shedding of the virus.

For more information, contact a Zoetis account manager or Zoetis Head Office on 0345 300 8034. 

Click here for more...
News Shorts
Bluetongue restricted zone extended

Following the discovery of a new case of bluetongue virus serotype 3 on the Buckinghamshire/Northamptonshire border, the restricted zone has been extended to include all of Northamptonshire.

The zone now covers Bedfordshire, Berkshire, Buckinghamshire, Cambridgeshire, City of Kingston upon Hull, East Riding of Yorkshire, East Sussex, Essex, Greater London, part of Hampshire, Hertfordshire, Kent, part of Leicestershire, Lincolnshire, Norfolk, Northamptonshire, Nottinghamshire, Suffolk, Surrey, and West Sussex.

Susceptible animals in the restricted zone should only be moved if it is essential. A specific licence is needed to move a susceptible animal from within the restricted zone to outside of the zone.

Bluetongue is a notifiable disease. Suspected cases must be reported on 03000 200 301 in England or 03003 038 268 in Wales. In Scotland, suspected cases should be reported to the local field services office. Suspected cases in Northern Ireland should be reported to the DAERA Helpline on 0300 200 7840 or by contacting the local DAERA Direct Veterinary Office.

A map of the area where movement restrictions apply can be found here.